Alkem Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,168.65
23.65 (0.46%)
BSENSE

Nov 20

BSE+NSE Vol: 72.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,168.65",
    "chg": 23.65,
    "chgp": "0.46%",
    "dir": 1,
    "prev_price": "5,145.00",
    "mcapval": "61,337.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE540L01014",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "72.33 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Gains 1.15%: 7 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-gains-115-7-key-factors-driving-the-weeks-mixed-momentum-4270434",
        "imagepath": "",
        "date": "2026-11-21 14:01:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Downgrade to Sell amid technical and financial concerns</p>\n                    <p><strong>17 Nov:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>18 Nov:</strong> Bearish technical shift despite modest price gain</p>\n                    <p><strong>19 Nov:</strong> Sharp open interest surge in derivatives amid mixed signals</p>\n                    <p><strong>19 Nov:</strong> Upgrade to Hold as technicals improve</p>\n                    <p><strong>20 Nov:</strong> Stock closes at ₹5,168.65, up 0.46% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item..."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-4268573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_oi_spurts_by_underlying_4268573.png",
        "date": "2026-11-19 15:01:07",
        "description": "Alkem Laboratories Ltd (ALKEM) has witnessed a notable 15.8% surge in open interest in its derivatives segment, signalling increased market activity despite the stock’s recent underperformance. This rise in open interest, coupled with volume patterns and shifting market positioning, offers insights into investor sentiment and potential directional bets in the mid-cap pharmaceutical stock."
      },
      {
        "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4267534",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_technicaldot_4267534.png",
        "date": "2026-11-19 08:04:55",
        "description": "Alkem Laboratories Ltd has witnessed a subtle but notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex interplay of market forces amid a challenging pharmaceutical sector environment."
      },
      {
        "title": "Alkem Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-4266039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_technicaldot_4266039.png",
        "date": "2026-11-18 08:04:38",
        "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite a modest day gain of 0.78%, the broader technical landscape suggests caution for investors as momentum oscillators and moving averages point towards weakening price strength."
      },
      {
        "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4264689",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_technicaldot_4264689.png",
        "date": "2026-11-17 08:03:16",
        "description": "Alkem Laboratories Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 0.59%, the stock’s technical landscape reveals a complex interplay of bearish and bullish signals across weekly and monthly timeframes, prompting a recent downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Alkem Laboratories Downgraded to Sell Amid Technical and Financial Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-technical-and-financial-concerns-4263250",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_mojoScore_4263250.png",
        "date": "2026-11-16 08:35:38",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 Nov 2026. This revision reflects deteriorating technical indicators, flat recent financial performance, and subdued long-term growth prospects, despite some strengths in management efficiency and valuation metrics."
      },
      {
        "title": "Alkem Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-ltd-faces-bearish-momentum-amid-technical-downgrade-4263094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_technicaldot_4263094.png",
        "date": "2026-11-16 08:03:33",
        "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects growing concerns over its price action and momentum metrics, as the stock underperforms relative to the broader market and its sector peers."
      },
      {
        "title": "Alkem Laboratories Declines 2.95% Amid Volatile Week and Heavy Put Option Activity",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-declines-295-amid-volatile-week-and-heavy-put-option-activity-4261715",
        "imagepath": "",
        "date": "2026-11-14 13:02:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> Stock opens strong at Rs.5,400 (+2.56%) outperforming Sensex</p>\n                    <p><strong>Nov 12:</strong> Heavy put option activity and sharp open interest surge amid price decline</p>\n                    <p><strong>Nov 12:</strong> Q2 FY27 results show strong revenue growth but margin and tax pressures</p>\n                    <p><strong>Nov 13:</strong> Stock closes week at Rs.5,110 (-4.22% on day), underperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,265.20</div></div>\n                    <div class=\"stat-ite..."
      },
      {
        "title": "Rs 5,200 Puts Draw 8,540 Contracts on Alkem Laboratories Ltd as Stock Dips Below Key Moving Averages",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/alkem-laboratories-sees-heavy-put-option-activity-amid-bearish-sentiment-4259593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AlkemLaboratori_most_active_stocks_puts_4259593.png",
        "date": "2026-11-12 15:00:08",
        "description": "The stock of Alkem Laboratories Ltd has slipped 3.52% today, underperforming its sector and the broader market, while 8,540 put contracts at the Rs 5,200 strike traded heavily ahead of the 23 November expiry. This surge in put activity, combined with the stock’s recent price action, suggests a nuanced picture of hedging and cautious positioning rather than outright bearish conviction."
      }
    ],
    "total": 189,
    "sid": "1000019",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Update On US FDA Inspection At CompanyS Manufacturing Facility Located At Amaliya Daman",
      "datetime": "19-Nov-2026",
      "details": "Please find attached herewith disclosure regarding update on US FDA inspection at Companys manufacturing facility located at Amaliya Daman",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "18-Nov-2026",
      "details": "Please find attached herewith Q2 H1FY2027 - Earnings Conference Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2026",
      "details": "Please find attached herewith intimation for a copy of newspaper publication.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Aug 26",
          "dt": "2026-08-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Update On US FDA Inspection At CompanyS Manufacturing Facility Located At Amaliya Daman

19-Nov-2026 | Source : BSE

Please find attached herewith disclosure regarding update on US FDA inspection at Companys manufacturing facility located at Amaliya Daman

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

18-Nov-2026 | Source : BSE

Please find attached herewith Q2 H1FY2027 - Earnings Conference Call Transcript

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2026 | Source : BSE

Please find attached herewith intimation for a copy of newspaper publication.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alkem Laboratories Ltd has declared 500% dividend, ex-date: 07 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available